# Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging

> **NCT04815603** · PHASE2 · WITHDRAWN · sponsor: **BioAge Labs, Inc.**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** BGE-117
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04815603
- **Lead sponsor:** BioAge Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-22
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The program priority for execution of this clinical trial changed prior to enrollment of the first patient. The study was not withdrawn due to any safety concerns.
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815603, "Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04815603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*